What You Should Know:
- symplr®, a provider of enterprise healthcare operations software announced its acquisition of the Smart Square® scheduling software from AMN Healthcare. This strategic move, backed by Clearlake Capital Group, L.P. and Charlesbank Capital Partners LLC, significantly strengthens symplr’s position in healthcare workforce and operations management, enhancing its symplr Operations Platform.
- The acquisition reinforces symplr’s commitment to providing intelligent,
Read More
Healthcare Leads in GenAI Adoption, But Faces Major Security and Infrastructure Hurdles
What You Should Know:
- Nutanix, a leader in hybrid multicloud computing, today announced the findings of its seventh annual global Healthcare Enterprise Cloud Index (ECI) survey and research report.
- The report reveals that an astonishing 99% of healthcare organizations surveyed are currently leveraging Generative AI (GenAI) applications or workloads, surpassing adoption rates in every other industry. However, this rapid embrace comes with significant challenges, as 96% of these
Read More
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
What You Should Know:
- Lunit, a provider of AI for cancer diagnostics and therapeutics announced a strategic collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions globally.
- The partnership, coupled with Lunit’s recent acquisition of Volpara (a Microsoft Industry Health Certified Partner), aims to provide health professionals worldwide with advanced tools for cancer detection.
Driving Scalable, Integrated AI in Healthcare
The strategic
Read More
KLAS Report: State of EHR Adoption in Asia & Oceania in 2025
What You Should Know:
- The healthcare technology landscape in Asia and Oceania is experiencing significant growth, driven by increasing digital maturity and a strong desire for enhanced interoperability, according to a new KLAS Research report. The report, "Asia/Oceania EHR 2025," reveals key trends in vendor performance and market share, highlighting a maturing market with evolving customer demands for value and up-to-date technology.
- The KLAS report, a follow-up to 2022 data,
Read More
Bluesight 2025 Report: How Software is Cutting Hospital Drug Diversion
What You Should Know:
- Bluesight, a leader in hospital intelligence solutions released its 2025 Diversion Trends Report, a comprehensive analysis highlighting the significant impact of software on the monitoring, prevention, and identification of controlled substance diversion in healthcare settings.
- The report, which analyzed over 266 million controlled substance transactions from more than 1,100 hospitals and health systems nationwide, offers crucial insights for
Read More
M&A: Nordic Capital Acquires Majority Stake in Arcadia
What You Should Know:
- Arcadia, a prominent healthcare data platform, and Nordic Capital, a private equity investor in healthcare and technology, today announced a strategic partnership under which Nordic Capital will become the majority owner of Arcadia.
- The strategic investment aims to accelerate Arcadia’s mission to expand its reach and deepen its impact on healthcare customers by providing a flexible, scalable platform and delivering more comprehensive data to inform
Read More
John Snow Labs Launches Spinoff Martlet.ai to Enable AI-Powered HCC Coding for Payers and Providers
What You Should Know:
- John Snow Labs, a prominent AI company in the healthcare sector, today announced the launch of Martlet.ai, a new healthcare AI company dedicated to redefining how payers and providers approach Hierarchical Condition Category (HCC) Coding.
- Founded by engineers and payment experts from John Snow Labs, Martlet.ai is the first of several planned spin-off companies aimed at tackling specific, high-impact challenges within the healthcare industry using
Read More
Catalio Capital Management Closes $400M+ Fund IV to Fuel Breakthrough Biomedical Innovation
What You Should Know:
- Catalio Capital Management, LP (“Catalio”), a healthcare investment firm, today announced the successful close of its fourth venture fund, Catalio Nexus Fund IV (“Fund IV”), with over $400M in commitments across the Fund and its related co-investment vehicles.
- Launched in 2020 by Co-Founders George Petrocheilos and Dr. Jacob Vogelstein, Catalio currently manages $2B in assets across its private equity, private credit, and public equities
Read More
Eko Health’s SENSORA Platform Gains CMS Reimbursement and CPT Code for AI-Powered Cardiac Detection
What You Should Know:
- Eko Health, a leader in AI-powered cardiac and pulmonary care, today announced a major stride in expanding access to early heart disease detection. The Centers for Medicare & Medicaid Services (CMS) has included Eko's SENSORA platform in its July 2025 provisional update to the Hospital Outpatient Prospective Payment System (OPPS), assigning SENSORA's Category III CPT code to APC 5734, with a reimbursement rate of $128.90 per use.
- The Category III
Read More
PathAI Granted FDA Clearance for AISight Dx for Primary Diagnosis in Clinical Settings
What You Should Know:
- PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its digital pathology image management system, AISight® Dx, for use in primary diagnosis in clinical settings.
- The FDA clearance builds upon the platform's initial 510(k) clearance for AISight Dx(Novo) in 2022, demonstrating PathAI’s ongoing commitment to innovation and
Read More
